BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The FENG//NONSGML v1.0//EN
BEGIN:VEVENT
UID:1783975370@thefeng.org
DTSTAMP:20260713T204250Z
DTSTART:20260722T160000Z
DTEND:20260722T170000Z
ORGANIZER;CN=Geeta Singh:MAILTO:geetagsiadvisory@gmail.com
SUMMARY:THE FENG: From Scrappy to Scaled:   The Strategic Rise of Fractional CFOs
LOCATION:Zoom
DESCRIPTION:From Scrappy to Scaled:The Strategic Rise of Fractional CFOsWhat to ExpectThe role of today's finance executive is evolving—particularly in the life sciences industry, where companies must balance innovation, capital efficiency, and growth through every stage of development. As organizations increasingly turn to fractional and interim finance leaders, experienced CFOs and finance executives are finding new ways to deliver strategic impact without a traditional full-time role.Join our Life Sciences/Pharma SIG meeting for a candid discussion on the rise of fractional finance leadership.Hear perspectives from both a leading fractional CFO firm and experienced independent executives as they explore how finance leadership needs evolve from early-stage startups to scaling organizations, what it takes to build a successful fractional practice, and the opportunities shaping the future of senior finance leadership in life sciences and pharma.Panelists:&nbsp;-&nbsp;Francisco Oliveira&nbsp; - Managing Director CFGO, Finance Operations &amp; Leadership for Life Science Innovators&nbsp;https://www.linkedin.com/in/franciscofoliveira/-&nbsp;Darlene Deptula-Hicks&nbsp; - Fractional CFO, Owner, Crimson Consulting, LLChttps://www.linkedin.com/in/darlenedeptulahicks/?skipRedirect=true-&nbsp;Alex Salcedo - Interim/Fractional CFO, Meadowland Capital Management, Inc.https://www.linkedin.com/in/alexsalcedo/&nbsp;Moderators- Marc Cote - Master Executive and Business Coach - FocalPoint&nbsp;https://www.linkedin.com/in/marc-r-cote/-&nbsp;Geeta Singh - Co-chair Life Sciences/Pharma SIG, Managing Director/Principal GSi Advisory, EIR&nbsp;
END:VEVENT
END:VCALENDAR